REGN

REGENERON PHARMACEUTICALS, INC.

Pharmaceutical Preparations · SIC 2834CIK 872589Held by 8 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

8 managers · Q2 2026 13F

13F bookWeight

Southeastern Asset Management

Mason HawkinsPosition history →

5.0%

+16.6%

$0.09B

$1.92B13F book · 2026-06-30

Sound Shore Management

Harry BurnPosition history →

2.4%

(15.9%)

$0.08B

$3.25B13F book · 2026-06-30

Dodge & Cox

Dodge & CoxPosition history →

1.6%

+9.3%

$3.04B

$191.01B13F book · 2026-06-30

Bridgewater Associates

Bridgewater AssociatesPosition history →

0.13%

+125.9%

$0.03B

$24.38B13F book · 2026-06-30

Renaissance Technologies

Renaissance TechnologiesPosition history →

0.13%

+121.9%

$0.09B

$72.62B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.07%

(18.9%)

$0.05B

$71.32B13F book · 2026-06-30

Capital World Investors

Capital World InvestorsPosition history →

0.06%

(42.6%)

$0.51B

$846.43B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.01%

+175.9%

$<0.01B

$21.33B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.